Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combination Product Regulation Will Come Under Scrutiny At May 1 Meeting

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed members will have an opportunity to voice concerns over combination product regulation at a May 1 meeting with FDA Combination Products Program Director Mark Kramer

You may also be interested in...



Industry, Rep. Buyer Urge Appropriators To Meet User Fee Funding Goals

Congress may reexamine the amount of funds allocated to the device user fee program in the omnibus FY 2003 spending bill, following the Feb. 3 release of President Bush's FY 2004 budget request, which designates only $1 mil. for premarket review activities at CDRH

Industry, Rep. Buyer Urge Appropriators To Meet User Fee Funding Goals

Congress may reexamine the amount of funds allocated to the device user fee program in the omnibus FY 2003 spending bill, following the Feb. 3 release of President Bush's FY 2004 budget request, which designates only $1 mil. for premarket review activities at CDRH

Potential Jurisdictional Change Draws Protest From Wound Product Firms

Wound healing products for which a primary mode of action cannot be elucidated should remain under the jurisdiction of FDA's device center, according to Apligraf manufacturer Organogenesis

Related Content

UsernamePublicRestriction

Register

MT016463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel